Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens

Advancement in immunogen selection and vaccine design that will rapidly elicit a protective Ab response is considered critical for HIV vaccine protective efficacy. Vaccine-elicited Ab responses must therefore have the capacity to prevent infection by neutralization-resistant phenotypes of transmitte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol
Main Authors: Hessell, Ann J., Malherbe, Delphine C., Pissani, Franco, McBurney, Sean, Krebs, Shelly J., Gomes, Michelle, Pandey, Shilpi, Sutton, William F., Burwitz, Benjamin J., Gray, Matthew, Robins, Harlan, Park, Byung S., Sacha, Jonah B., LaBranche, Celia C., Fuller, Deborah H., Montefiori, David C., Stamatatos, Leonidas, Sather, D. Noah, Haigwood, Nancy L.
Formato: Artigo
Idioma:Inglês
Publicado em: AAI 2016
Assuntos:
Immunotherapy and Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4797725/
https://ncbi.nlm.nih.gov/pubmed/26944928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1500527
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados